Febustat 80 mg is an advanced anti-hyperuricemic agent used for the chronic management of hyperuricemia in patients with gout. As a non-purine, selective xanthine oxidase inhibitor, Febustat targets the enzyme responsible for uric acid production, effectively reducing elevated serum uric acid levels. By controlling uric acid levels, it helps prevent gout attacks, joint damage, and other complications associated with chronic hyperuricemia.

Febustat 80 mg is specifically indicated for patients with symptomatic gout and is not recommended for the treatment of asymptomatic hyperuricemia.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Febustat 80 mg is indicated for:

• Chronic management of hyperuricemia in patients with gout

• Prevention of recurrent gout attacks through long-term uric acid control

Dosage and Administration

Recommended Dosage:

• Initial dose: 40 mg once daily

• If serum uric acid remains above 6 mg/dL after 2 weeks, increase to 80 mg once daily

• Can be taken with or without food

• No dose adjustment is required in patients with mild to moderate renal or hepatic impairment

Administration Guidelines:

• Take orally at the same time each day

• Adherence to therapy is essential for optimal uric acid control

• Consider prophylactic therapy (e.g., NSAIDs or colchicine) during the first six months to reduce the risk of gout flares

Mechanism of Action

Febustat selectively inhibits xanthine oxidase, the enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid. This action decreases uric acid production without affecting other enzymes involved in purine and pyrimidine metabolism. By reducing uric acid levels, Febustat lowers the risk of urate crystal deposition, inflammation, and gout attacks.

Contraindications

• Hypersensitivity to Febuxostat or any component of the formulation

• Concomitant use with azathioprine, mercaptopurine, or theophylline due to risk of severe toxicity

Side Effects

Common adverse effects may include:

• Liver function abnormalities

• Nausea

• Arthralgia (joint pain)

• Rash

Precautions:

• Gout flare: May increase during initial therapy; prophylactic NSAID or colchicine may help

• Cardiovascular events: Monitor for signs of myocardial infarction or stroke

• Liver enzyme elevation: Regular monitoring of liver function tests is recommended

Drug Interactions

• Concomitant administration with azathioprine, mercaptopurine, or theophylline may increase plasma concentrations and toxicity

• Monitor for drug interactions in patients on multiple medications

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Special Populations

• Pregnancy (Category C): Use only if benefits outweigh risks; unknown if excreted in human milk

• Pediatric: Safety and efficacy not established in patients under 18 years

• Geriatric: No specific dosage adjustments required, but monitor for sensitivity

Overdose

• Febustat has been studied in healthy subjects up to 300 mg daily for seven days without evidence of dose-limiting toxicity

• Management of overdose is supportive and symptomatic

Storage Conditions

• Store below 30°C, protected from light and moisture

• Keep out of reach of children

Summary

Febustat 80 mg is a selective xanthine oxidase inhibitor that effectively reduces serum uric acid levels in patients with gout. It provides a targeted approach for chronic hyperuricemia management, helping to prevent recurrent gout attacks and complications. Regular monitoring of liver function and cardiovascular status ensures safe and effective therapy.